The MedTech regulatory landscape is in flux. The rate of technological innovation is faster than regulators can keep up, especially with today's shorter product life cycles. Software in particular has disrupted the established regulatory order. In this environment, it is important to communicate with regulatory agencies early and often. Learn more in our summary of a recent webinar.